ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för posaconazole. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

15 träffar

Bibliografisk träff 2012-06-01

Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome.

Vehreschild JJ, Müller C, Farowski F, Vehreschild MJ, Cornely OA, Fuhr U, Kreuzer KA, Hallek M, Kohl V.

Eur J Clin Pharmacol · journal article · DOI 10.1007/s00228-012-1212-y

Bibliografisk träff 2012-03-16

Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis.

Salas V, Pastor FJ, Calvo E, Sutton DA, Chander J, Mayayo E, Alvarez E, Guarro J.

J Antimicrob Chemother · journal article · DOI 10.1093/jac/dks090

Bibliografisk träff 2012-03-05

Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring.

Dolton MJ, Ray JE, Marriott D, McLachlan AJ.

Antimicrob Agents Chemother · review-article; review; journal article · DOI 10.1128/aac.05900-11

Bibliografisk träff 2012-03-04

Successful treatment of cutaneous zygomycosis with extensive surgical debridement and oral posaconazole in an immunocompetent patient.

Laza-Stanca V, Reid L, Watson JD, Williamson EC.

J Plast Reconstr Aesthet Surg · journal article; case reports · DOI 10.1016/j.bjps.2012.02.009

Bibliografisk träff 2012-03-02

Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.

Chishimba L, Niven RM, Cooley J, Denning DW.

J Asthma · journal article · DOI 10.3109/02770903.2012.662568

Bibliografisk träff 2012-02-28

Impact of benzodiazepines on posaconazole serum concentrations. A population-based pharmacokinetic study on drug interaction.

Heinz WJ, Grau A, Ulrich A, Helle-Beyersdorf A, Zirkel J, Schirmer D, Lenker U, Einsele H, Klinker H.

Curr Med Res Opin · clinical trial; journal article · DOI 10.1185/03007995.2012.664123

Bibliografisk träff 2012-02-13

Efficacy of posaconazole in murine experimental sporotrichosis.

Fernández-Silva F, Capilla J, Mayayo E, Guarro J.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.05376-11

Bibliografisk träff 2012-02-01

Posaconazole: the case for therapeutic drug monitoring.

Howard SJ, Felton TW, Gomez-Lopez A, Hope WW.

Ther Drug Monit · research support, non-u.s. gov't; review; journal article · DOI 10.1097/ftd.0b013e31823cdeac

Bibliografisk träff 2012-02-01

A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy.

Huang X, Wang F, Chen Y, Liu T, Wang J, Hu J, Jie J, Chen F, Wang S, Shen Z, Yu L, Yu K, Liang Y.

Future Microbiol · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.2217/fmb.11.158

Bibliografisk träff 2012-01-30

In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.

Salas V, Pastor FJ, Calvo E, Alvarez E, Sutton DA, Mayayo E, Fothergill AW, Rinaldi MG, Guarro J.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.05956-11

Bibliografisk träff 2012-01-01

Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease.

O'Sullivan AK, Weinstein MC, Pandya A, Thompson D, Langston AA, Perfect JR, Papadopoulos G.

Am J Health Syst Pharm · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.2146/ajhp110149

Bibliografisk träff 2011-12-19

Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers.

Krishna G, Ma L, Prasad P, Moton A, Martinho M, O'Mara E.

Expert Opin Drug Metab Toxicol · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1517/17425255.2012.639360

Bibliografisk träff 2011-12-06

A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.

Elewski B, Pollak R, Ashton S, Rich P, Schlessinger J, Tavakkol A.

Br J Dermatol · clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1365-2133.2011.10660.x

Bibliografisk träff 2011-11-04

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.

Ananda-Rajah MR, Grigg A, Downey MT, Bajel A, Spelman T, Cheng A, Thursky KT, Vincent J, Slavin MA.

Haematologica · research support, non-u.s. gov't; research-article; journal article · DOI 10.3324/haematol.2011.051995

Bibliografisk träff 2011-07-18

Posaconazole: when and how? The clinician's view.

Katragkou A, Tsikopoulou F, Roilides E, Zaoutis TE.

Mycoses · review; journal article · DOI 10.1111/j.1439-0507.2011.02061.x